Cas:131614-43-2 [1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene manufacturer & supplier

We serve Chemical Name:[1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene CAS:131614-43-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

[1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene

Chemical Name:[1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene
CAS.NO:131614-43-2
Synonyms:[1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene
Molecular Formula:C58H54Cl2P2Ru
Molecular Weight:984.97300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:27.18000
Exact Mass:984.21200
LogP:7.53640

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like [1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene Use and application,[1-[2-(bis-p-tolylphosphanyl)-1-naphthyl]-2-naphthyl]-bis(p-tolyl )phosphane, dichlororuthenium, 1-isopropyl-4-methyl-benzene technical grade,usp/ep/jp grade.


Related News: The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). tert-butyl (R)-2,2-dimethyl-4-((pyridin-2-yloxy)methyl)oxazolidine-3-carboxylate manufacturers Expedite biocatalysis development by partnering with an API CDMO 3,4,5-triethoxy-N-phenylbenzamide suppliers The company pinpointed Thousand Oaks for its expansion “based on capability, staffing as well as the local community and the things we could bring to the area,” Hatke, told the news outlet. 6-methoxy-4-((4-(3-methoxyprop-1-yn-1-yl)benzofuran-7-yl)amino)-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile hydrochloride vendor & factory.